Despite widespread efforts at prevention and advances in diagnosis and treatment, cardiovascular disease remains the leading cause of death in the United States and affects nearly 50% of individuals in the US aged 20 years or older.
1,2 In addition, it is estimated that the annual financial burden of heart disease in the United States is more than $200 billion.
1 Although many cardiovascular risk factors are known (eg, hypertension, diabetes, and smoking), the persistent public health impact of cardiovascular disease mandates a more complete understanding of novel risk factors.
1,3 A recent study has shown that the intensity of thyroid hormone treatment is a modifiable risk factor for incident atrial fibrillation and stroke
4; however, its association with cardiovascular mortality remains unclear.